Results 261 to 270 of about 18,925,600 (331)

Glyoxal induces arterial injury through the inactivation of receptors and signaling pathways. [PDF]

Mol Cell Biochem
Xie MZ, Yang X, Wu ZW, Zhou LP, Chu HX, Zhang QM, Zhang YC, Zhou XC, Zhao MM, Mo QJ, Wang XF, Xv WD, Bian WY, Li YN.   +13 more
europepmc   +1 more source

Exerkines in precision management of metabolic diseases. [PDF]

Chin Med J (Engl)
Jin L, Lin Y, Zheng Y, Wang A, Liao P, Luo Y, Sui Z, Ni X, Zhang J, Shen Q, Xu A.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Insulin-Like Growth Factor-II

, 2016
M. Shimizu
semanticscholar   +2 more sources

Insulin-Like Growth Factor-II

, 1994
A 67 amino acid peptide, structurally similar to IGF-I (somatomedin C), but having greater insulin-like activity, and less growth promoting activity. Both IGF-I and IGF-II share structural similarities with proinsulin.
J. Seth
semanticscholar   +2 more sources

Primary structure of human insulin‐like growth factor II [PDF]

FEBS Letters, 1978
E. Rinderknecht, R. Humbel
semanticscholar   +3 more sources

Parental imprinting of the mouse insulin-like growth factor II gene.

Cell, 1991
We are studying mice that carry a targeted disruption of the gene encoding insulin-like growth factor II (IGF-II). Transmission of this mutation through the male germline results in heterozygous progeny that are growth deficient. In contrast, when the disrupted gene is transmitted maternally, the heterozygous offspring are phenotypically normal ...
T. Dechiara, E. Robertson, A. Efstratiadis   +2 more
semanticscholar   +3 more sources

Synthetic insulin-like growth factor II

Biochemical and Biophysical Research Communications, 1985
Human insulin-like growth factor II with 67 amino acid residues and three disulfide bridges has been synthesized by the solid-phase method. Homogeneity of the synthetic product is ascertained by chromatofocusing, high performance liquid chromatography and amino acid analysis.
C H, Li, D, Yamashiro, R G, Hammonds, M, Westphal   +3 more
openaire   +2 more sources

Insulin‐Like Growth Factor II Effects Mediated through Insulin‐Like Growth Factor II Receptors

Acta Paediatrica, 1990
ABSTRACT. Insulin‐like growth factor II (IGF‐II) resembles the homologous peptide insulin‐like growth factor I (IGF‐I) in that it stimulates cellular growth in vitro. This effect is generally believed to be mediated through IGF type 1 receptors; the role of the IGF type 2 receptor remains, as yet, unknown.
M, Tally, K, Hall
openaire   +2 more sources

Chemical synthesis of insulin‐like growth factor II

International Journal of Peptide and Protein Research, 1985
Human insulin‐like growth factor II (IGF‐II) with 67 amino acids and three disulfide bridges has been synthesized by the solid‐phase method. The synthetic hormone is shown to be homogeneous in high performance liquid chromatography (HPLC), high performance partition chromatography (HPPC), and chromatofocusing.
D, Yamashiro, C H, Li
openaire   +2 more sources

Immunoreactive insulin-like growth factor II in urine

Acta Endocrinologica, 1990
Abstract. Insulin-like growth factor II and insulin-like growth factor binding protein-1 were identified and quantified in the urine of 23 healthy subjects between 17 and 76 years of age. IGF-II was measured after separation by gel chromatography at low pH and compared with IGF-I levels in the same samples, whereas IGF binding protein-1 was measured in
W, Zumkeller, K, Hall
openaire   +2 more sources